Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tetra Bio Pharma Inc TBPMQ

Healthcare Drug Manufacturers - Major Cannabis
Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.


GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > Eye treatment news cadmium funds
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(328)
•••
Comment by Golddetectoron Apr 27, 2022 9:22am
87 Views
Post# 34635092

RE:Eye treatment news cadmium funds

RE:Eye treatment news cadmium funds

This is very weird no NR. It is significant 5M free money. Is there something else coming from Tbp? Reduvo Din? QIXLEEF? They want to announce 1st? Below is the link for Tbp research for eye drop and earlier partnership 2years ago with Altus 

https://ca.paidpromotionalmessages.com/companies/news/948447/tetra-bio-pharma-to-reactivate-clinical-trial-to-evaluate-veterinary-drug-ppp-003v-to-treat-indolent-corneal-ulcers-in-companion-animals-948447.html
 

https://tallcinc.com/tetra-bio-pharma-and-altus-formulation-form-new-company-tallc-to-exploit-ta-a001/

Below the link to yesterday news. 5 million funds including government funds. Strange Tbp did not announce that.

https://cqdm.org/news-and-events/cqdm-funds-an-innovative-project-with-altus-formulation-and-tetra-bio-pharma-to-develop-first-in-class-treatments-for-ocular-inflammation/

[/quote]

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities